Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acer Therapeutics Inc (NQ: ACER )

2.680 USD -0.020 (-0.74%)
Official Closing Price Updated: 4:00 PM EST, Dec 2, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 146,700
Open 2.700
Bid (Size) 2.610 (2)
Ask (Size) 2.730 (11)
Prev. Close 2.700
Today's Range 2.600 - 2.740
52wk Range 1.080 - 7.250
Shares Outstanding 7,497,433
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Acer Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Schubert Firm Investigating Possible Breaches of Fiduciary Duty by Acer Therapeutics Inc. Officers and Directors
Schubert Jonckheer & Kolbe LLP is investigating potential shareholder derivative claims on behalf of stockholders of Acer Therapeutics Inc. (NYSE: ACER) related to the company's statements about its... 
From PR Newswire

Performance

YTD
-29.29%
-29.29%
1 Month
+1.52%
+1.52%
3 Month
+1.52%
+1.52%
6 Month
-17.79%
-17.79%
1 Year
-22.99%
-22.99%

More News

Read More
Acer Therapeutics to Present at the Virtual BIO Investor Forum Digital
From GlobeNewswire News Releases
Acer Therapeutics to Virtually Present at Upcoming Investor Conferences
From GlobeNewswire News Releases
ACER LONG TERM SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Acer Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
From Business Wire News Releases
Investor Ideas Adds New Biotech (Nasdaq: ACER) (Nasdaq: AIKI) (Nasdaq: JAN) (TSXV: MDP) and Gaming / eSport Stocks (Nasdaq: SLGG)
Tags Financial
From Investorideas.com newswire, breaking stock news and business news
Acer Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
Acer Therapeutics Investors Who Have Held Their Stock Continuously Since at Least September 25, 2017 Are Encouraged to Contact Kehoe Law Firm, P.C.
From GlobeNewswire News Releases
How The Parts Add Up: VTI Targets $186
Tags ETFs
From ETF Channel
Shareholder Alert: Robbins LLP Announces the Shareholder Class Action Against Acer Therapeutics Inc. (ACER) Survives Motion to Dismiss
From Business Wire News Releases
NASDAQ: ACER Shareholder Notice: Update in Lawsuit Against Acer Therapeutics Inc.
From SBWire - Latest Press Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.